Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients

Clinical trial NCT02474316 · UNKNOWN

Trial details

NCT number: NCT02474316
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2014-08-01
Primary completion: 2017-12-01
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.